Under otherwise identical conditions, deoxyspergualin preferentially inhibits the growth of the T-cell leukemia line L5178y; an effective dose for a 50%inhibition (ED50) of 0.0007 m was determined. A much weaker cytostatic activity was found for murine lymphocytes (ED50: approximately 25 jum) and for CV-1 monkey kidney cells (ED50: 16.3 jum). Deoxyspergualin causes biphasic and differential effects on DNAmetabolism of murine T and B in organ transplantation.
DEOXYSPERGUALXN, A POTENT ANTITUMOR AGENT :
FURTHER STUDIES ON THE CYTOBIOLOGICAL MODE OF ACTION JULY 1987 Werner E. G. Muller, Norbert Weissmann, Armin Maidhof, Michael Bachmann and Heinz C. Schroder
Institut fur Physiologische Chemie, Universitat, Duesberg-Weg 6, D-6500 Mainz, West Germany (Received for publication October 29, 1986) Under otherwise identical conditions, deoxyspergualin preferentially inhibits the growth of the T-cell leukemia line L5178y; an effective dose for a 50%inhibition (ED50) of 0.0007 m was determined. A much weaker cytostatic activity was found for murine lymphocytes (ED50: approximately 25 jum) and for CV-1 monkey kidney cells (ED50: 16.3 jum). Deoxyspergualin causes biphasic and differential effects on DNAmetabolism of murine T and B At lower concentrations (0.3~5^m) the [3H]TdR incorporation into nonlipopolysaccharide-activated lymphocytes is significantly stimulated by the this effect was not observed with lymphocyte cultures stimulated with conThis change of TdR incorporation rates was found to parallel with the DNA polymerase a activity. Deoxyspergualin causes an additive effect bleomycin and a significant synergistic cytostatic effect in combination with avarol and avarone. Moreover, it is reported that deoxyspergualin causes neither a selective inhibitory effect on DNA-,RNA-or protein synthesis nor an alteration of the intracellular distribution pattern of the Ro and La antigens. However, detailed enzymic studies revealed that deoxyspergualin reduces DNApolymerase a but not j3 activity in lymphocytes at the ED50concentration of this compound. These results support previous documentations that deoxyspergualin is of potential clinical usefulness (a) in treatment of certain tumors and (b) in organ transplantation.
15-Deoxyspergualin is a derivative of the antitumor antibiotic spergualin1'^, which was discovered in the culture filtrates of the bacterial strain BMG162-aF2.The pharmacological activities of deoxyspergualin and spergualin are characterized by the following properties ; (a) strong antitumor activity in vitroz:> and in vivo2\ (b) moderate activity against a series of microorganisms2), and (c) prolonged graft survival time in several transplantation models4). From these data it was concluded19 that deoxyspergualin/spergualin combines strong antitumor (anti-leukemic) activity (at low doses of the compounds) with immunosuppressive action (at high doses of the compounds). The cyto-biological modeof action causing this obvious specific dualistic effect is not known.
In this paper we describe (a) the cell specific cytotoxic effect caused by deoxyspergualin in vitro as well as (b) further cyto-biological experiments, helping to understand the mode of action of the compound. (pH 6.0) . Bleomycin (clinical mixture, containing 55~70% A2; 25~32% B2; <7% A2; and <1% B4) was obtained from H. Mack, Illertissen, West Germany. Avarol and avarone were prepared as described, and stored in dimethyl sulfoxide6).
Materials and Methods

Materials
Cell Culture L5178ymouse lymphomacells7) were grownin Eagle's minimumessential mediumsupplemented with 10%fetal calf serum in roller tubes8»9). For the dose response experiments, 5-ml cultures were initiated by inoculation of 5 x 103 cells/ml and were incubated at 37°C for 72 hours; the controls showed a generation time of 12.5 hours. The cell growth was estimated by cell count with a Cytocomp counter (128-channel counter; system Michaelis; Mainz, West Germany)10). In the absence of inhibitors, the cell concentration after a 72-hour incubation period was determined to be 2.8 x 105 cells/ml.
Mixed lymphocyte cultures were performed as described10'n). Spleen lymphocytes were prepared from NMRImice. Macrophage-containing lymphocytes (2.5 x 106 cells) were placed into a final volume of 200 [A in microtiter plates and incubated for 72 hours in Dulbecco's minimal essential medium supplemented with 10% fetal calf serum. 18 hours prior to the end of the incubation 0.1^Ci of [3H]TdR was added to each cup. Where indicated 2 ,ag/ml of Con A or 20^g/ml of LPS were added to the cultures. Incorporation of [3H]TdRwas determined as described10>n). The compounds were added at time zero to the cultures.
CV-1 monkey kidney cells (ATCCCCL70) were cultivated in monolayer cultures in growth medium supplemented with 10%fetal calf serum12). The cells were planted at a density of 5 X 104 cells per 60-mm plastic petri dish (Falcon Plastics) and incubated for 72 hours in the presence of the compounds in 5%CO26). At the end, the cell number was determined. The generation time was 20.4 hours; the cell concentration at the end of the incubation period was 2.4 x 105 cells/plate.
All cell culture experiments were performed in fetal calf serum which contained only very little amine oxidase. Applying the described assay procedure3), the level of amine oxidase was determined to be less than 1 x 10"6 m H2O2generated per 30 minutes.
Each value came from 10 parallel experiments. The ED50 concentrations (50% effective inhibitory dose) causing a 50% inhibition of cell growth (in the experiments with L5178y and CV-1 cells) or a 50 % reduction of [3H]TdR incorporation (in the studies with mixed murine lymphocytes) were estimated by logit regression13).
The mathematical evaluation of the fractional inhibitory concentration index (FIC indexes) of deoxyspergualin given in combination with bleomycin, avarol or avarone were performed according to published equations14) and experimental procedures150. FIC> 1 , antagonism; FIC= 1 , additive effects ; FIC<1, suggestive of synergism; FIC<0.5, significant synergism. These studies were performed with L5178y cells (5,000 cells/ml as initial concentration; incubation period: 72 hours).
Incorporation of Nucleic Acid and Protein Precursors For the determination of DNA,RNAand protein synthesis, 5-ml suspensions of exponentially growing L5178y cells at 100,000 cells/ml were treated for 24 hours with deoxyspergualin. The labeled precursors (10 /^Ci each/5-ml culture) were added 1 hour prior to harvest to the cultures. Samples of 1 ml were analyzed for cell concentration (results given in number of doubling steps16)) and for acidinsoluble radioactivity17).
Assay of DNAPolymerase Activities in Lymphocytes
The culture conditions for mixed lymphocytes were essentially as described above. DNApolymerase a and /3 activities in macrophage containing lymphocytes were determined exactly as described previously18). Briefly, the enzymes were extracted from 108 cells, 72 hours after addition of deoxyspergualin. Where indicated 2 jug Con A/ml or 20^g LPS/ml were added to the cultures. The two DNApolymerases were separated by sucrose gradient centrifugation. Then the fractions from the gradient were collected and the enzyme activities were determined18). The DNApolymerase a mixture consisted of (0.1 him concentrations each) [3H]dCTP (specific activity 30 cpm/pmol), dATP, dGTP, dTTP, 20 mMpotassium phosphate buffer (pH 7.2), 1 mM2-mercaptoethanol, 8 him MgCl2, and 0.5 A260 units of activated herring sperm DNA.The DNApolymerase /3 mixture was identical with the polymerase a mixture, except that 50 mMammediol (pH 8.8), rather than potassium phosphate, was used as buffer. Before being mixed with the reaction mixture for DNApolymerase /3, the enzyme fraction was preincubated at 0°C with 0.5 mMiV-ethylmaleimide for 10 minutes. The activities are given as nmol of radioactive deoxyribonucleotide incorporated per hour.
Monoclonal Antibodies Against La and Ro Antigens The preparation of monoclonalantibodies against homogeneous Ro and La antigens was described previously19).
Immunofluorescence Microscopy CV-1 cells were grown for 72 hours on cover-slips in the presence of 0 or 16.3 /um (=ED50 concentration; Table 1 ) of deoxyspergualin. Then the cells were fixed and stained directly with fluorescein isothiocyanate coupled anti-Ro or anti-La monoclonal antibodies as described previously193.
Results
Cytostatic
Activity It has been shownpreviously that the amine oxidase level present in serum used for in vitro culturing of cells can strongly influence the cytotoxic effect of deoxyspergualin50. Therefore we have performed all of our in vitro studies with fetal calf serum, which was determined to lack almost completely amine oxidase. Under identical incubation conditions deoxyspergualin strongly inhibited the proliferation of the T-lymphoma cell line L5178y (ED50: 0.0007 /^m); Table 1 . CV-1 monkey kidney cells and mixed murine lymphocytes were far more resistant towards this antibiotic. This is in contrast to the experiments with bleomycin, which caused an inhibition of the different cell types at almost identical concentrations.
Avarol and avarone inhibited primarily growth of L5178y cells and of lymphocytes, while CV-1cells were almost insensitive towards these compounds.
Interesting was the finding that deoxyspergualin differentially influenced [3H]TdR incorporation into DNAof murine T and B lymphocytes (Fig. 1) . The baseline incorporation rates in the cultures were as follows; without mitogen, 0.69dz0.1 x lO3 dpm/106 cells per 18 hours and in the presence of 2pg Con A/ml or 20pg LPS/ml, 17.9±1.1 XlO3 dpm or 14.8±1.0xl08 dpm/106 cells per 18 hours, respectively. The Con A-activated lymphocytes showed a typical dose-response curve without any mented at a deoxyspergualin concentration within the range 0.3^5 jum. The maximal stimulation was measured at 0.5~1.0 //m with 173% (controls: 100%) for LPS-stimulated cells and with 1 50 % for non-stimulated lymphocytes.
To rule out the possibility that the changes of the measured thymidine incorporation rates are due to possible changes in the thymidine pool sizes during incubation, additional enzymic studies were performed. The results revealed that in the absence of deoxyspergualin (Fig. 2) both Con A and LPS caused an increase of the DNApolymerase a activity in the lymphocytes. DNApolymerase /3 activity was found to be not influenced under these conditions. A quantitative comparison showed ( Table 2 ) that LPS and Con A caused a 4.1-fold and 4.4-fold increase of DNApolymerase activity. Addition of 1^m deoxyspergualin resulted in an increase of DNA polymerase a activity only in the controls (1.3-fold) and in LPS-treated lymphocytes (1.4-fold), but not in Con A-treated cells (Table 2) . Hence, we have two independent series of experiments from which weconclude that deoxyspergualin caused a stimulation of DNAsynthesis in LPS-stimulated and non-stimulated lymphocytes.
Influence on Synthesis of Macromolecules In Vitro
This set of experiments was performed with exponentially growing L5178y cells. The cells were incubated for 24 hours at different concentrations of deoxyspergualin; the radioactively labeled precursors were added 1 hour prior to harvest. Both cell growth and incorporation rate were determined ( Table 3 ). The results revealed that almost parallel with the reduction of the growth rates (given in doubling steps per 24 hours) the incorporation rates of all three precursors decreased. A more detailed analysis of the deoxyspergualin effect on the level of DNApolymerases revealed ( Table 2 ) that this compound, at the respective ED50concentrations (summarized in Table 1 ), caused a 1.7-fold reduction of DNApolymerase a activity in control lymphocytes and a 5.8-fold reduction or 3.9-fold reduction in LPS-or Con A-treated spleen cells ; DNApolymerase /3 activity was not influenced at all. Fromthese findings we conclude that at least one modeof action of deoxyspergualin is the inhibition of DNApolymerase a activity in the intact cell system.
Combination Studies of Deoxyspergualin with Bleomycin and Avarol
Given in combination the two polyamine containing compoundsdeoxyspergualin and bleomycin Mixed lymphocyte cultures were incubated in the absence (®) or the presence of 2^g Con A/ml (O) or 20 [Jig LPS/ml (å¡) in the standard assay. Then the cells were harvested and homogenized. The cell free supernatant extracts were run through sucrose gradients. Theresulting fractions were analyzed for DNApolymerase a and p activities.
Details are given under "Methods", a and /3 mark the respective DNApolymerase. Table 2 . DNA polymerase activities in cells from mousespleen. Mixed lymphocyte cultures were prepared and incubated in the absence or presence of mitogens (20 jug LPS/ml or 2^g Con A/ml) as well as in the absence or the presence of deoxyspergualin. DNA polymerase activities were determined after separation of the lymphocyte extracts by sucrose density gradient centrifugation (see Fig. 2 ). Further details are given under "Methods".
DNApolymerase activity Table 4 . However, if deoxyspergualin was added to the cultures in combination with avarol or avarone a strong synergistic inhibitory interaction was determined (FIC values : 0.29~0.42).
Effect on the Intracellular
Distribution of the Ro and La Antigens
By applying direct immuno-cytochemical procedures, we recently described that in CV-1 cells (a) The experiments were performed as described under "Methods". The values represent means of five parallel experiments. The SD does not exceed 10%.
Incorporation into macromolecules/1 00,000 cells the La antigen is localized predominantly in the nucleus and (b) the Ro antigen resides primarily in the cytoplasm18). The staining pattern obtained with monoclonal antibodies against La is of the speckled type ( Fig. 3a) and that against Ro of a fibrous type (Fig. 3c) . These characteristic patterns were found to remain unchanged even after an incubation of the CV-1cells for 72 hours in the presence of the ED50concentration (=16.3 jum) of deoxyspergualin (Figs. 3b and 3d ).
Discussion
From the foregoing results it is obvious that deoxyspergualin causes a strong anti-leukemic activity in vitro, as determined with the L5178y mouse lymphoma cell line. The cytostatic activity against this cell line (ED50: 0.0007 jum) is several thousand-fold higher compared to the one determined for murine normal lymphocyte cultures (ED50: approximately 25 jum), under otherwise identical culture conditions. This finding was unexpected and requires further investigations.
One possible reason for the obtained differential cytostatic activity could be a difference in the level of amine oxidase. This enzyme was Deoxyspergualin is a polyamine-like compound^. Hence it was interesting to determine its in vitro effect when it is co-administered with the polyamine containing cytostatic agent bleomycin. Using L5178ycell system we established that these two compoundsaffect cell growth in an additive manner. This finding might have some impact on future clinical trials. Although bleomycin, a DNA-degrading compound20), and deoxyspergualin, an agent which does not change the integrity of DNA,have different modes of action on the molecular level, they cause only an additive inhibitory effect in the intact cell system. The inability of deoxyspergualin to induce breakage of an isolated covalently closed circular DNA(pBR322) was found in in vitro studies (unpublished). Moreover, we established deoxyspergualin not to cause frame-shift and point mutations in the Salmonella mutagenicity test system (unpublished). On the other hand the "T-rymphotropic" and anti-human T-lymphotropic retroviral agents avarol and avarone10'21) , which interfere with microtubule formation during mitotic events22) , were determined to act highly synergistically in combination with deoxyspergualin. Hence, the combination of deoxyspergualin with the antimitotic agent avarol for the treatment of leukemia in vivo is warranted ; animal experiments with the L5178ymouse lymphomasystem are currently being performed.
A further important result, presented in this paper, is the finding that the [3H]TdR incorporation rate as well as the activity of DNApolymerase a of non-stimulated as well as LPS-stimulated mixed lymphocyte cultures is significantly enhanced in the presence of sub-cytostatic concentrations of deoxyspergualin. This finding is in contrast to the data obtained with Con A-stimulated lymphocytes, which do not show this effect. Fromthese results we conclude that deoxyspergualin displays a biphasic effect on non-stimulated lymphocytes and B lymphocytes; activation of blastogenesis at lower doses of deoxyspergualin and suppression of this response at higher compounddoses. Onthe other side, T lymphocytes are only monophasically affected (suppression of blastogenesis) by deoxyspergualin. Hence, these in vitro data support previous conclusions, that spergualin or its analogues might be potentially useful in organ transplantation4).
The molecular modeof action of deoxyspergualin remains unclear. First, we established that it causes no specific effect on overall synthesis of macromolecules (DNA, RNAand protein) in vitro. However, detailed enzymic studies revealed that deoxyspergualin reduced DNApolymerase a activity in lymphocytes which had been treated with this compound at ED50 concentrations. In contrast, DNA polymerase /3 activity remained unchanged even under those concentrations of deoxyspergualin which caused a 50%reduction of [3H]TdR incorporation rate. Furthermore, this cytostatic agent does not alter the intracellular distribution of the Ro and La antigens, which are frequently found in sera from patients suffering from systemic lupus erythematosus18 > 23).
